RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Windtree Therapeutics Stock

Windtree Therapeutics ROE 2024

Windtree Therapeutics ROE

-5.98

Ticker

WINT

ISIN

US97382D3035

WKN

A2P3ZQ

In 2024, Windtree Therapeutics's return on equity (ROE) was -5.98, a 52.8% increase from the -3.92 ROE in the previous year.

Windtree Therapeutics Aktienanalyse

What does Windtree Therapeutics do?

Windtree Therapeutics is an emerging biotechnology company based in Pittsburgh, Pennsylvania. The company was founded in 2011 and specializes in the development of innovative therapies for respiratory diseases. Windtree Therapeutics aims to improve the lives of millions of people worldwide by providing effective and safe medications. History: Windtree Therapeutics has a history that dates back to 1990 when it was founded as Advanced Inhalation Research, focusing on the development of therapies for respiratory diseases. After several rounds of financing and mergers, the company was eventually revived as Windtree Therapeutics. Since then, the company has developed and marketed a range of innovative therapies that improve the lives of millions of patients with respiratory diseases. Business model: Windtree Therapeutics is a biotechnology company focused on the development and commercialization of therapies for respiratory diseases. The company has a strong ethos for innovation and works closely with leading medical and scientific experts to develop high-quality and safe products. The company holds a variety of patents and unique technologies that allow it to improve its competitive position in the industry. Segments: Windtree Therapeutics operates in two business segments: PneumRX® Bronchial Tubes and KL4-Surfactant Technology. PneumRX® Bronchial Tubes: One of Windtree Therapeutics' main segments is the PneumRX® Bronchial Tube technology. This technology aims to improve the lives of patients with chronic obstructive pulmonary disease (COPD). The PneumRX® tubes are used as minimally invasive procedures to open the lumen of the bronchial tubes and facilitate breathing. The technology has already been used in thousands of patients worldwide and is highly regarded by physicians. KL4-Surfactant Technology: Windtree Therapeutics is also known for its KL4-Surfactant Technology, which aims to treat respiratory distress syndrome in newborns. The company has already conducted a number of clinical studies, and the results have been very promising. The KL4-Surfactant Technology is considered one of the most promising treatment options for respiratory problems in newborns. Products: Windtree Therapeutics has a range of products on the market, including: Aer-OS Nitric Oxide Inhalation Device: The Aer-OS Nitric Oxide Inhalation Device is a medical device for patients with pulmonary hypertension. It is the first and only portable nitric oxide inhalation device approved for use at home and on-the-go. The device is used to facilitate breathing and improve patients' quality of life. PneumRX® Bronchial Tubes: The PneumRX® Bronchial Tube technology has already been performed in thousands of patients and is highly regarded by physicians. The technology aims to open the lumen of the bronchial tubes and facilitate breathing. The procedures are minimally invasive and result in minimal injuries. Patients often experience significant improvement in their breathing and overall well-being. KL4-Surfactant Technology: Windtree Therapeutics' KL4-Surfactant Technology is a promising treatment option for respiratory problems in newborns. The technology aims to stimulate lung growth and facilitate breathing. The results of clinical studies have been very promising, and the treatment is considered one of the most promising treatment options for respiratory problems in newborns. In conclusion, Windtree Therapeutics is an emerging biotechnology company with a strong ethos for innovation and the development of therapies for respiratory diseases. The PneumRX® Bronchial Tube technology and KL4-Surfactant Technology are two of the company's main segments. Both technologies are promising and have the potential to improve the lives of millions of patients worldwide. Windtree Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Windtree Therapeutics's Return on Equity (ROE)

Windtree Therapeutics's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Windtree Therapeutics's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Windtree Therapeutics's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Windtree Therapeutics’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Windtree Therapeutics stock

What is the ROE (Return on Equity) of Windtree Therapeutics this year?

The ROE of Windtree Therapeutics this year is -5.98 undefined.

How has the Return on Equity (ROE) of Windtree Therapeutics developed compared to the previous year?

The ROE of Windtree Therapeutics has increased by 52.8% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Windtree Therapeutics?

A high ROE indicates that Windtree Therapeutics generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Windtree Therapeutics?

A low ROE can indicate that Windtree Therapeutics is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Windtree Therapeutics affect the company?

A change in ROE (Return on Equity) of Windtree Therapeutics can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Windtree Therapeutics?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Windtree Therapeutics?

Some factors that can influence Windtree Therapeutics's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Windtree Therapeutics pay?

Over the past 12 months, Windtree Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Windtree Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Windtree Therapeutics?

The current dividend yield of Windtree Therapeutics is .

When does Windtree Therapeutics pay dividends?

Windtree Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Windtree Therapeutics?

Windtree Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Windtree Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Windtree Therapeutics located?

Windtree Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Windtree Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Windtree Therapeutics from 11/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did Windtree Therapeutics pay the last dividend?

The last dividend was paid out on 11/4/2024.

What was the dividend of Windtree Therapeutics in the year 2023?

In the year 2023, Windtree Therapeutics distributed 0 USD as dividends.

In which currency does Windtree Therapeutics pay out the dividend?

The dividends of Windtree Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Windtree Therapeutics

Our stock analysis for Windtree Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Windtree Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.